InDevR launches VaxArray Measles and Rubella Kit for improved vaccine antigen characterization

InDevR launches VaxArray Measles and Rubella Kit for improved vaccine antigen characterization

BOULDER -- InDevR, Inc. announced commercial availability of its VaxArray Measles and Rubella (MR) antigen quantification kit. Funded by the Bill and Melinda Gates Foundation with the goal of... Read More

Tuesday January 19, 2021 0 comments Tags: Boulder, InDevR, Erica Dawson, VaxArray Measles and Rubella Kit

InDevR expands commercial portfolio for coronavirus vaccine characterization 

InDevR expands commercial portfolio for coronavirus vaccine characterization 

BOULDER -- InDevR, Inc. , a life science tools company providing powerful analytical technologies to support the development and production of vaccines and biotherapeutics, announced commercial... Read More

Thursday December 10, 2020 0 comments Tags: Boulder, InDevR, Kathy Rowlen, VaxArray, COVID-19

InDevR delivers commercial multiplex Coronavirus SeroAssay kit and testing services for vaccine development 

InDevR delivers commercial multiplex Coronavirus SeroAssay kit and testing services for vaccine development 

BOULDER -- InDevR, Inc. , a leader in novel analytical technologies that support the development and production of vaccines and biotherapeutics, announced commercial availability of its COVID-19... Read More

Wednesday June 17, 2020 0 comments Tags: Boulder, InDevR, Coronavirus SeroAssay, COVID-19, Kathy Rowlen

InDevR raises $7M in series A round with Adjuvant Capital investment

InDevR raises $7M in series A round with Adjuvant Capital investment

BOULDER -- InDevR, Inc. , a biotechnology company focused on developing and commercializing novel analytical technologies for biologic process development and monitoring, announced it has raised... Read More

Tuesday September 10, 2019 0 comments Tags: Boulder, InDevR, Adjuvant Capital, Glenn Rockman, Kathy Rowlen

InDevR launches next-gen software for Cypher One

InDevR launches next-gen software for Cypher One

BOULDER -- InDevR, Inc. , an innovative life science company dedicated to improving biopharmaceutical and vaccine manufacturing, today announced the global launch of the next-generation Cypher... Read More

Tuesday March 21, 2017 0 comments Tags: Boulder, InDevR, Cypher One, Dawn Bitz

InDevR licenses FDA influenza antibodies for VaxArray potency platform

InDevR licenses FDA influenza antibodies for VaxArray potency platform

BOULDER -- InDevR , a Boulder-based progressive analytical technology and life science instrumentation company, today announced it has entered into an agreement to license monoclonal antibodies... Read More

Tuesday January 17, 2017 0 comments Tags: Boulder, InDevR, FDA, VaxArray, Dr.Kathy Rowlen, influenza

InDevR appoints Dawn Bitz chief commercial officer

InDevR appoints Dawn Bitz chief commercial officer

BOULDER -- InDevR , a Boulder-based progressive analytical technology, life science instrumentation and medical device company, announced the appointment of Dawn Bitz as VP, Chief Commercial... Read More

Wednesday June 29, 2016 0 comments Tags: Boulder, InDevR, Dawn Bitz, Kathy Rowlen

CBSA: 2014 was successful year for major bioscience financings, acquistions and expansions

CBSA: 2014 was successful year for major bioscience financings, acquistions and expansions

DENVER - The Colorado BioScience Association (CBSA) reports the state attained a number of key financings, acquisitions and expansions in its bioscience industry in 2014. "We've seen a... Read More

By: InnovatioNews Tuesday December 23, 2014 0 comments Tags: April Giles, CBSA, Clovis Oncology, Covidien, Denver, InDevR, N30 Pharmaceuticals, SomaLogic, Spectranetics, Terumo BCT